Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Depressive Disorders: MDD and Dysthymia01:27

Depressive Disorders: MDD and Dysthymia

1.2K
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
1.2K
Long-term Depression01:05

Long-term Depression

33.8K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
33.8K
Long-term Depression01:03

Long-term Depression

3.6K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
3.6K
Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Depressive Disorders: Etiology01:27

Depressive Disorders: Etiology

872
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
872

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A CAPTURE ancillary study to assess GOLD 2025 spirometry recommendations in primary care adults.

Annals of the American Thoracic Society·2026
Same author

Maintenance of an Asthma Intervention Post-Trial: Use of a Patient-Activated Reliever-Triggered Inhaled Corticosteroid (PARTICS) Strategy in Black and Latinx Patients.

Journal of the American Board of Family Medicine : JABFM·2025
Same author

Differences in COPD management across clinician type: Maintenance treatment habits and patient characteristics among US pulmonologists, internal/family medicine physicians, nurse practitioners, and physician assistants.

Chronic respiratory disease·2025
Same author

Adverse Outcomes Associated With Inhaled Corticosteroid Use in Individuals With Chronic Obstructive Pulmonary Disease.

Annals of family medicine·2025
Same author

Improving Patient-Centric COPD Management.

Federal practitioner : for the health care professionals of the VA, DoD, and PHS·2025
Same author

Author Correction: Best practice advice for asthma exacerbation prevention and management in primary care: an international expert consensus.

NPJ primary care respiratory medicine·2025
Same journal

Advancing Family Medicine Through Dyadic Electronic Medical Record Linkage in Dementia Care.

Annals of family medicine·2026
Same journal

Association of General Practice Continuity With Hospital Admissions and Costs: A Retrospective Study.

Annals of family medicine·2026
Same journal

Association of Advanced Access With Primary Care Performance: A Systematic Review.

Annals of family medicine·2026
Same journal

Death by Rousui in Japan: Rethinking Death, Diagnosis, and Care in an Aging Society.

Annals of family medicine·2026
Same journal

Navigating Changing Waters, Staying Anchored in Our Values at the 2026 ADFM Annual Conference.

Annals of family medicine·2026
Same journal

Multicomponent School of Caring Program to Support Caregivers of Patients With Dementia: A Quasi-Experimental Effectiveness Study in Primary Care.

Annals of family medicine·2026
See all related articles

Related Experiment Video

Updated: Apr 12, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.7K

Repeated depression screening during the first postpartum year.

Barbara P Yawn1, Susan Bertram2, Marge Kurland2

  • 1Olmsted Medical Center, Department of Research, Rochester, Minnesota byawn@olmmed.org.

Annals of Family Medicine
|May 13, 2015
PubMed
Summary
This summary is machine-generated.

Repeated postpartum depression (PPD) screening at 6 and 12 months identifies more women at high risk. This enhanced screening increases PPD identification rates in the first year postpartum.

Keywords:
PHQ-9postpartum depressionpractice-based researchscreening

More Related Videos

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.8K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.4K

Related Experiment Videos

Last Updated: Apr 12, 2026

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.7K
MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder
08:20

MRI-guided dmPFC-rTMS as a Treatment for Treatment-resistant Major Depressive Disorder

Published on: August 11, 2015

14.8K
Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method
07:12

Individualized rTMS Treatment for Depression using an fMRI-Based Targeting Method

Published on: August 2, 2021

4.4K

Area of Science:

  • Obstetrics and Gynecology
  • Psychiatry
  • Public Health

Background:

  • Postpartum depression (PPD) screening is recommended between 4-12 weeks postpartum.
  • Linking screening to management programs improves outcomes.
  • The value of repeated PPD screening within the first year is not well-established.

Purpose of the Study:

  • To evaluate the benefit of repeated postpartum depression screening at 6 and 12 months.
  • To determine the additional PPD cases identified by repeated screening.

Main Methods:

  • A substudy of the Translating Research into Practice for Postpartum Depression (TRIPPD) study.
  • Utilized Patient Health Questionnaire (PHQ-9) scores from mailed questionnaires.
  • Assessed women at baseline (4-12 weeks), 6 months, and 12 months postpartum.

Main Results:

  • At 6 months, 10.9% of women with initially negative screens (PHQ-9 < 10) had elevated scores.
  • At 12 months, an additional 6.1% of women with initially negative screens had elevated scores.
  • Repeated screening identified 193 women (13.5%) at high risk for PPD.

Conclusions:

  • Repeated postpartum depression screening at 6 and 12 months significantly increases the identification of women at high risk.
  • Further research is needed to ascertain the impact of this repeated screening on patient outcomes.